WASHINGTON — The Food and Drug Administration has been without a permanent leader for 10 months in large part because of the Senate confirmation process. Key Democrats have voiced public complaints about nearly every potential agency leader, including longtime agency veteran and acting commissioner Janet Woodcock.
Robert Califf isn’t going to have any easier of a time if he gets the nod.
Biden is vetting Califf, a cardiologist and clinical trial expert who served as FDA commissioner during the Obama administration, for the permanent job, the Washington Post first reported Thursday. A White House official said in a statement: “There has not been a decision made for the FDA commissioner.”
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.
Already have an account? Log in
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect